RDD Pharma entered into a letter of intent to acquire Naia Rare Diseases in a move to boost its gastrointestinal drug pipeline.
Abbvie committed the fourth largest corporate bond sale of all time when it sold $30 billion worth of bonds to partially finance its $83 billion takeover of Allergan.
Becker’s ASC Review revisited the Atlanta Gastroenterology Associates and Frazier Healthcare Partners deal (almost) a year later to present insights into what’s happened since. Read more.
CRH Medical continues to bring in the revenue in 2019, posting $30.4 million in third-quarter revenues, up from $28.7 million in the same period last year. Read more.
Exact Sciences closed its $2.8 billion acquisition of Genomic Health Nov. 8, securing rights to Genomic’s diagnostic oncology test, Oncotype DX.
Boston Medical Center is studying how Motus GI’s Pure-Vu System affects bowel preparation in a clinical setting.
Danville, Pa.-based Geisinger Health and Pittsburgh-based Highmark Health broke ground on a medical clinic in Lock Haven, Pa.
More articles on surgery centers:
CMS to pay for total knees in ASCs, boost ASC payment rate 2.6% in 2020: 4 details
With $60B+ deals this year, what’s in store for private equity in the future?
Texas health system building ASC — 4 insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
